These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 8174467)
1. [The usefulness of serum antibody to Epstein-Barr virus-specific DNAase (EDAb) in early detection of nasopharyngeal carcinoma]. Huang D Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):289-91. PubMed ID: 8174467 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus seroepidemiology in China. Zeng Y; Pi GH; Deng H; Zhang JM; Wang PC; Wolf H; De Thé G AIDS Res; 1986 Dec; 2 Suppl 1():S7-15. PubMed ID: 3030349 [TBL] [Abstract][Full Text] [Related]
3. Outcome of patients with positive Epstein-Barr virus serologic status in the absence of nasopharyngeal carcinoma in Hong Kong. Lo S; Ho WK; Wei WI Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):770-2. PubMed ID: 15210561 [TBL] [Abstract][Full Text] [Related]
4. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282 [TBL] [Abstract][Full Text] [Related]
5. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma. Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of Epstein-Barr viral serology in nasopharyngeal carcinoma. Low WK; Leong JL; Goh YH; Fong KW Otolaryngol Head Neck Surg; 2000 Oct; 123(4):505-7. PubMed ID: 11020195 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC). Liu MT; Yeh CY Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898 [TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis and long-term follow up study of asymptomatic nasopharyngeal carcinoma patients]. Ji MF; Guo YQ; Zheng SA; Liang JS; Wang DK; Ou XT Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):53-6. PubMed ID: 12778770 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma. Liu MY; Chang YL; Ma J; Yang HL; Hsu MM; Chen CJ; Chen JY; Yang CS J Med Virol; 1997 Jul; 52(3):262-9. PubMed ID: 9210034 [TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma. Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805 [TBL] [Abstract][Full Text] [Related]
11. Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs. Hao SP; Tsang NM; Chang KP Cancer; 2003 Apr; 97(8):1909-13. PubMed ID: 12673717 [TBL] [Abstract][Full Text] [Related]
12. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia. Karray H; Ayadi W; Fki L; Hammami A; Daoud J; Drira MM; Frikha M; Jlidi R; Middeldorp JM J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486 [TBL] [Abstract][Full Text] [Related]
13. Antibody to Epstein-Barr virus-specific DNase as a marker for the early detection of nasopharyngeal carcinoma. Chen JY; Liu MY; Chen CJ; Hsu MM; Tu SM; Lee HH; Kuo SL; Yang CS J Med Virol; 1985 Sep; 17(1):47-9. PubMed ID: 2995572 [TBL] [Abstract][Full Text] [Related]
14. Plasma Epstein-Barr virus immunoglobulin A and DNA for nasopharyngeal carcinoma screening in the United States. O TM; Yu G; Hu K; Li JC Otolaryngol Head Neck Surg; 2007 Jun; 136(6):992-7. PubMed ID: 17547994 [TBL] [Abstract][Full Text] [Related]
15. [Early diagnosis of nasopharyngeal carcinoma using recombinant antigens expressed in bacteria]. Wan Z; Pi G; Sun N Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):74-6. PubMed ID: 12515179 [TBL] [Abstract][Full Text] [Related]
16. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma. Liu MY; Huang YT; Sheen TS; Chen JY; Tsai CH J Med Virol; 2004 Aug; 73(4):574-82. PubMed ID: 15221902 [TBL] [Abstract][Full Text] [Related]
17. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx]. Mazeron MC Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277 [TBL] [Abstract][Full Text] [Related]
18. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma. Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420 [TBL] [Abstract][Full Text] [Related]
19. [The diagnosis of nasopharyngeal carcinoma (author's transl)]. Arnold W; Nakazima A; Wang YB; Vosteen KH; Brunner H; Göbel U HNO; 1980 Aug; 28(8):247-60. PubMed ID: 6254933 [TBL] [Abstract][Full Text] [Related]
20. Serum responses to the combination of Epstein-Barr virus antigens from both latent and acute phases in nasopharyngeal carcinoma: complementary test of EBNA-1 with EA-D. Chow KC; Ma J; Lin LS; Chi KH; Yen SH; Liu SM; Liu WT; Chen WK; Chang TH; Chen KY Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):363-8. PubMed ID: 9149897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]